SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-046176
Filing Date
2023-04-17
Accepted
2023-04-17 16:07:04
Documents
14
Period of Report
2023-06-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm232020d1_pre14a.htm PRE 14A 680898
2 GRAPHIC tm232020d1_pre14a-img11.jpg GRAPHIC 2784
3 GRAPHIC tm232020d1_pre14a-img12.jpg GRAPHIC 3497
4 GRAPHIC tm232020d1_pre14a-img14.jpg GRAPHIC 81726
5 GRAPHIC tm232020d1_pre14a-img15.jpg GRAPHIC 87298
6 GRAPHIC tm232020d1_pre14a-img16.jpg GRAPHIC 3553
7 GRAPHIC tm232020d1_pre14a-img17.jpg GRAPHIC 133158
8 GRAPHIC tm232020d1_pre14a-img18.jpg GRAPHIC 114842
9 GRAPHIC tm232020d1_pre14a-img19.jpg GRAPHIC 91552
10 GRAPHIC tm232020d1_pre14a-img20.jpg GRAPHIC 94304
11 GRAPHIC tm232020d1_pre14a002.jpg GRAPHIC 3428
12 GRAPHIC tm232020d1_pre14a003.jpg GRAPHIC 877
13 GRAPHIC tm232020d1_pre14a004.jpg GRAPHIC 924
14 GRAPHIC tm232020d1_pre14aimg001.jpg GRAPHIC 15684
  Complete submission text file 0001104659-23-046176.txt   1556787
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33958 | Film No.: 23824020
SIC: 2834 Pharmaceutical Preparations